HL

HealthStream IncFRA HealthStream Stock Report

Last reporting period 30 Sep, 2024

Updated 30 Oct, 2024

Last price

Market cap $B

0.87

Micro

Exchange

XFRA - Deutsche Boerse AG

HL5.F Stock Analysis

HL

Neutral

Based on Eyestock quantitative analysis, HL5.F`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

82/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

27.6 %

Undervalued

Market cap $B

0.87

Dividend yield

0.46 %

Shares outstanding

30.582 B

HealthStream, Inc. engages in the provision of services to healthcare organizations. The company is headquartered in Nashville, Tennessee and currently employs 1,135 full-time employees. The company went IPO on 2000-04-11. Its solutions help to onboard, retain, engage, educate, manage and develop workforce talent; meet rigorous governance, risk, and compliance requirements; optimize staff scheduling and capacity management; and automate the management of medical staff credentialing, privileging, and enrollment. The company operates through two segments. Its workforce solutions are subscription-based products and are used by healthcare organizations to meet a range of their clinical development, talent management, training, certification, engagement, scheduling, competency assessment, performance appraisal and additional needs. Its provider solutions are offered through the Company’s business segment, which is branded in the marketplace as VerityStream. VerityStream delivers enterprise-class solutions to transform the healthcare provider experience for healthcare organizations and providers.

View Section: Eyestock Rating